Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers
- 1 May 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 26 (5) , 871-877
- https://doi.org/10.1097/hjh.0b013e3282f624d9
Abstract
Few studies have examined microalbuminuria (MAU) in non-western populations. We assessed the prevalence of MAU in the general population of a middle-income country in the African region and relationships between MAU and selected cardiovascular risk factors. An examination survey was conducted in a sample representative of the entire population aged 25–64 years in the Seychelles. MAU adjusted for urine creatinine concentration was measured on the second morning urine using a semiquantitative point-of-care analyzer. A total of 1255 persons attended the survey (participation rate of 80.2%). The age-adjusted prevalence of MAU was 11.4%. At age 25–64 years, the prevalence of MAU was 5% in persons without diabetes and hypertension, 20% in persons with either condition and 41% in persons with both conditions. The overall prevalence of stages 3–4 chronic kidney disease was low at 3.2%. In multivariate analysis, MAU was associated with age [odds ratio (OR) 1.24 for a 10-year increase; 95% confidence interval (CI): 1.02–1.52], hypertension stage I (2.0; 1.1–3.8) and stage II (4.5; 2.3–8.6), obesity (1.7; 1.0–2.8) and diabetes (3.0; 1.9–4.9). These associations were virtually unchanged upon further adjustment for markers of renal function such as serum creatinine, serum cystatin C and calculated renal function. The prevalence of MAU was high in this population, and MAU was strongly associated with several cardiovascular risk factors independently of renal function markers. These findings suggest that MAU could be a useful marker of cardiovascular risk in this population and help identify persons in need of a specific cardiovascular risk management.Keywords
This publication has 37 references indexed in Scilit:
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2007
- How to measure renal function in clinical practiceBMJ, 2006
- Renal Disease in Obesity: The Need for Greater AttentionJournal of Renal Nutrition, 2006
- Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)Clinical Therapeutics, 2006
- Microalbuminuria and Coronary Heart Disease Risk in an Ethnically Diverse UK PopulationJournal of the American Society of Nephrology, 2005
- Strategies for national health care systems in emerging countries: The case of screening and prevention of renal disease progression in BoliviaKidney International, 2005
- Screening for Microalbuminuria: Which Measurement?Diabetic Medicine, 1991
- Single-Void Urine Samples Can Be Used To Estimate Quantitative MicroalbuminuriaDiabetes Care, 1987
- Microalbuminuria as a predictor of clinical diabetic nephropathyKidney International, 1987
- MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUSThe Lancet, 1982